These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30242998)

  • 1. Association of sTNFR1 and BNP Levels with Diminished Estimated Glomerular Filtration Rate in Type 2 Diabetic Egyptian Patients.
    Mokhtar ER; M E; Hassan MA; Abou-ELHassan HA; Alanany MG; Hasuna MA
    Egypt J Immunol; 2018 Jan; 25(1):57-69. PubMed ID: 30242998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
    Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
    J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH; Chang TT; Chu CH; Huang CC; Lin LY
    Clin Chim Acta; 2024 May; 558():117880. PubMed ID: 38555050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
    Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.
    Chang LH; Hwu CM; Chu CH; Lin YC; Huang CC; You JY; Chen HS; Lin LY
    J Endocrinol Invest; 2021 Dec; 44(12):2609-2619. PubMed ID: 33834419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.
    Saulnier PJ; Gand E; Velho G; Mohammedi K; Zaoui P; Fraty M; Halimi JM; Roussel R; Ragot S; Hadjadj S;
    Diabetes Care; 2017 Mar; 40(3):367-374. PubMed ID: 27998909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP; Tuohy C; Doody A; Jackson S; Canavan RJ; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    Sci Rep; 2020 Sep; 10(1):14852. PubMed ID: 32908199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus.
    Chang LH; Hwu CM; Lin YC; Huang CC; Won JGS; Chen HS; Lin LY
    Endocr Pract; 2020 Oct; 26(10):1115-1124. PubMed ID: 33471713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
    Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
    Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria.
    Seki N; Nishimura M; Matsumoto T; Fukazawa M; Kenmochi T
    J Diabetes Complications; 2013; 27(1):92-7. PubMed ID: 22885249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria.
    Miyazawa I; Araki S; Obata T; Yoshizaki T; Morino K; Kadota A; Ugi S; Kawai H; Uzu T; Nishio Y; Koya D; Haneda M; Kashiwagi A; Maegawa H
    Diabetes Res Clin Pract; 2011 May; 92(2):174-80. PubMed ID: 21288590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between the Brain Natriuretic Peptide (BNP) Level and Prognosis of Diabetic Nephropathy with Microalbuminuria: A 7-Year Follow-Up Study.
    Seki N; Matsumoto T; Fukazawa M
    Horm Metab Res; 2018 May; 50(5):389-396. PubMed ID: 29723897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failure.
    Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Grigorian L; Bertomeu V; Rivera M
    Peptides; 2012 Feb; 33(2):354-8. PubMed ID: 22281024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural damage in diabetic nephropathy is associated with TNF-α system activity.
    Fernández-Real JM; Vendrell J; García I; Ricart W; Vallès M
    Acta Diabetol; 2012 Aug; 49(4):301-5. PubMed ID: 22042131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
    Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
    Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
    Takase H; Dohi Y
    Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.
    Fadini GP; Bonora BM; Albiero M; Zaninotto M; Plebani M; Avogaro A
    Cardiovasc Diabetol; 2017 Feb; 16(1):22. PubMed ID: 28183314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.